Research study Program year 2022 Source: CMS Open Payments

A Randomized Double Blind Placebo Controlled Phase III Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate the Efficacy at 16 Weeks and to Assess the Long Term Efficacy Safety and Tolerability Up to 52 Weeks in Patients With

Research payments

$5,056,499

73 payments

Through program year 2022, $5,056,499 in research payments was reported against A Randomized Double Blind Placebo Controlled Phase III Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate the Efficacy at 16 Weeks and to Assess the Long Term Efficacy Safety and Tolerability Up to 52 Weeks in Patients With, across 73 payments, paid by Novartis Pharmaceuticals Corporation.

Paid by: Novartis Pharmaceuticals Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$10,762	14
2020	Research	$2,222,623	24
2019	Research	$2,823,114	35

Breakdown

Who paid Research payments · program years 2019–2022

Novartis Pharmaceuticals Corporation $5,056,499 73 payments

Who received the money Research payments · program years 2019–2022

The Center For Rheumatology LLP Organisation paid for research $758,723 3 payments
St Joseph39s Health System Organisation paid for research $468,908 2 payments
Low Country Rheumatology PA Organisation paid for research $405,952 3 payments
Altoona Center For Clinical Research Organisation paid for research $355,117 2 payments
Tekton Research Organisation paid for research $335,592 3 payments
Joint And Muscle Research Institute Organisation paid for research $333,108 2 payments
Arthritis And Rheumatology Center Of Oklahoma Pllc Organisation paid for research $325,495 2 payments
Malcom Randall Va Medical Center Organisation paid for research $315,934 2 payments
Rheumatology Associates PC Organisation paid for research $227,103 3 payments
Ohsu Hospital And Clinics Teaching hospital · OR $191,921 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Cite this record

“A Randomized Double Blind Placebo Controlled Phase III Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate the Efficacy at 16 Weeks and to Assess the Long Term Efficacy Safety and Tolerability Up to 52 Weeks in Patients With”, Who Paid My Doc, citing CMS Open Payments, program year 2022. https://www.whopaidmydoc.com/research-studies/a-randomized-double-blind-placebo-controlled-phase-iii-multicenter-study-of-subcutaneous-secukinumab-in-prefilled-syringes-to-demonstrate-the-efficacy-at-16-weeks-and-to-assess-the-long-term-efficacy-safety-and-tolerability-up-to-52-weeks-in-patients-with-211741269

Figures here may be reproduced with attribution and a link — see for journalists and researchers.